a triple-blind, randomized, active-controlled, parallel-group, multicenter study to evaluate and compare the efficacy and tolerability of alendronate sodium [alendronic acid] with calcium supplementation in the treatment of osteoporosis in postmenopausal women.
Phase of Trial: Phase III
Latest Information Update: 30 Jan 2009
At a glance
- Drugs Alendronic acid; Calcium carbonate
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Merck & Co
- 10 Jun 2017 Biomarkers information updated
- 25 Nov 2006 New trial record.